title: Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
authors.affiliation: Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: J
authors.initials: J
authors.lastname: Thorp
authors.forename: S
authors.initials: S
authors.lastname: Palacios
authors.forename: J
authors.initials: J
authors.lastname: Symons
authors.forename: J
authors.initials: J
authors.lastname: Simon
authors.forename: K
authors.initials: K
authors.lastname: Barbour
mesh_terms: D000328:Adult; D001562:Benzimidazoles / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects*; D010549:Personal Satisfaction; D011788:Quality of Life; D012725:Sexual Behavior; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy* / Q000523:psychology; D012747:Sexual Partners / Q000523:psychology*; D013315:Stress, Psychological / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D001562:Benzimidazoles; D000697:Central Nervous System Stimulants; C098107:flibanserin